Empagliflozin restores chronic kidney disease–induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction
Open Access
- 22 December 2020
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 99 (5), 1088-1101
- https://doi.org/10.1016/j.kint.2020.12.013
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- Renal Dysfunction in Patients With Heart Failure With Preserved Versus Reduced Ejection FractionCirculation: Heart Failure, 2012
- Inhibition of mitochondrial fission prevents cell cycle progression in lung cancerThe FASEB Journal, 2012
- FGF23 induces left ventricular hypertrophyJCI Insight, 2011
- Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family membersDiabetes Therapy, 2010
- Interrelations of mitochondrial fragmentation and cell death under ischemia/reoxygenation and UV‐irradiation: Protective effects of SkQ1, lithium ions and insulinFEBS Letters, 2008
- Mitochondrial fragmentation in neurodegenerationNature Reviews Neuroscience, 2008
- Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imagingKidney International, 2006
- Endothelial Nitric Oxide Synthase in Vascular DiseaseJournal of the American College of Cardiology, 2006
- Oxidative consumption of nitric oxide: A potential mediator of uremic vascular diseaseKidney International, 2003
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney International, 2002